SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-19-037999
Filing Date
2019-02-13
Accepted
2019-02-13 16:17:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d678646dsc13ga.htm SC 13G/A 32822
  Complete submission text file 0001193125-19-037999.txt   34602
Mailing Address 5-1, NIHONBASHI 3-CHOME CHUO-KU, TOKYO M0 103-8426
Business Address 5-1, NIHONBASHI 3-CHOME CHUO-KU, TOKYO M0 103-8426 (011) 81-3-5255-7041
Daiichi Sankyo Company, LTD (Filed by) CIK: 0001340156 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Subject) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88402 | Film No.: 19597367
SIC: 2836 Biological Products, (No Diagnostic Substances)